CBD is generally safe for dogs at moderate doses, based on the research available so far. Safety studies have given dogs up to 5 mg/kg of body weight daily for three months and up to 10 mg/kg daily for 36 weeks without serious health problems. But “generally safe” comes with important caveats: CBD can elevate liver enzymes, interact with other medications, and product quality varies wildly in an unregulated market. What you give your dog and what’s actually in the bottle may not be the same thing.
What the Safety Studies Show
The most reassuring evidence comes from a 36-week study in which dogs received daily CBD supplements. At 5 mg/kg per day, researchers found no significant adverse events, and the dogs’ overall health was the same at the end of the study as it was at the beginning. At the highest dose tested (10 mg/kg per day), some dogs developed loose stools and one liver enzyme was consistently elevated, though not enough to be considered clinically significant.
Across multiple studies at Cornell University and elsewhere, the pattern is similar: dogs tolerate CBD well at doses in the 1 to 5 mg/kg range. Owners rarely report behavioral side effects. The side effects that do show up tend to be mild, mostly soft stools and occasional lethargy.
The Liver Enzyme Issue
Nearly every canine CBD study has flagged the same finding: an increase in alkaline phosphatase (ALP), a liver enzyme. This has appeared in arthritis studies at 2 mg/kg, epilepsy studies at 2.5 mg/kg, and safety studies at higher doses. The elevations haven’t led to liver failure or clinical illness in any published study, but the FDA has stated that the effects of CBD on the liver in animals need to be more completely understood before a definitive safety conclusion can be made.
This matters most for dogs who already have liver issues or who take other medications processed by the liver. Signs of liver problems to watch for include vomiting, diarrhea, decreased appetite, and general fatigue. Yellowing of the eyes or skin suggests more advanced liver disease and needs immediate veterinary attention.
Drug Interactions Are a Real Concern
CBD inhibits several liver enzymes responsible for breaking down common medications. When two substances compete for the same metabolic pathway, one or both can build up to higher-than-intended levels in the body. This is the same reason grapefruit juice carries warnings with certain human medications.
Clinically significant interactions have been documented with the anti-seizure drug clobazam, the blood thinner warfarin, and the immune suppressant tacrolimus. CBD also affects the pathways that process phenobarbital, a seizure medication commonly prescribed for dogs. This creates a tricky situation: CBD is most often given to dogs with epilepsy or pain, and those dogs are frequently already on medications that could interact with it.
If your dog takes any prescription medication, this is the single most important reason to involve your veterinarian before starting CBD. The interaction risk isn’t theoretical. It’s been documented in clinical settings.
Where CBD Has Shown Benefits
Arthritis and Pain
The strongest evidence for CBD in dogs involves osteoarthritis pain. In one study, full-spectrum CBD oil significantly reduced pain severity scores by an average of 2.23 units from baseline. The doses used in most arthritis studies range from 1 to 2.5 mg/kg given twice daily. A meta-analysis of three studies found that CBD may reduce both pain severity and how much pain interferes with daily activity, though the researchers rated the certainty of evidence as very low due to small sample sizes and inconsistent results across trials.
In practical terms, owners in these studies reported their dogs were more comfortable and mobile. No side effects were reported by owners in the Cornell arthritis study, though blood work did show the characteristic bump in liver enzymes.
Seizures
Dogs with epilepsy that received CBD alongside their regular anti-seizure medication experienced a median 33% reduction in seizure frequency compared to dogs receiving a placebo. The dose used was higher than for arthritis, at 2.5 mg/kg twice daily. A separate set of studies using a broad-spectrum CBD product at 4.5 mg/kg twice daily found a 25 to 30 percent seizure reduction. These are meaningful improvements, but not dramatic. The proportion of dogs achieving a 50% or greater reduction in seizures was similar between the CBD and placebo groups, meaning CBD helped reduce the total number of seizures without necessarily producing a strong response in most individual dogs.
Why Product Quality Matters So Much
No CBD product for pets has been approved, conditionally approved, or indexed by the FDA. The 2018 Farm Bill legalized hemp but explicitly preserved the FDA’s authority to regulate CBD products, and the agency has made regulation of the CBD market a priority. In practice, though, enforcement is limited, and the market is flooded with products of wildly uneven quality.
Data from the Merck Veterinary Manual highlights the consequences. In cases reported to poison control, 30% of dogs who consumed CBD products showed lethargy, 21% had trouble walking (ataxia), and 6 to 7% experienced trembling, heightened sensitivity to touch, or urinary incontinence. These signs are more consistent with THC intoxication than CBD, suggesting the products were contaminated with unlabeled THC, synthetic cannabinoids, or other compounds. Poorly manufactured products may also contain heavy metals or have CBD concentrations that don’t match what’s on the label.
A certificate of analysis (COA) from an independent, third-party lab is the minimum standard you should expect from any CBD product. The COA should confirm the actual CBD concentration matches the label, that THC content is below 0.3%, and that the product has been screened for pesticides, heavy metals, and pathogens. If a company doesn’t make its COA easily available, that alone is a reason to choose a different product.
THC Is the Bigger Danger
Dogs are far more sensitive to THC than humans are. CBD itself has a low affinity for the cannabinoid receptors (CB1 and CB2) in the brain that produce the “high” associated with marijuana. It actually works as a partial blocker of those receptors when THC is also present. THC, by contrast, activates those receptors directly, and dogs appear to have more of them than humans do.
Full-spectrum CBD products legally contain up to 0.3% THC. At appropriate CBD doses, this trace amount is unlikely to cause problems. But if a dog eats an entire bottle of treats or oil, even 0.3% THC in a large volume of product can add up. Broad-spectrum products (THC removed) and CBD isolates eliminate this risk, though they may also lack other hemp compounds that some researchers believe contribute to CBD’s effects.
Practical Dosing Guidance
Research points to a dose range of 1 to 2.5 mg/kg of body weight, given twice daily, for arthritis pain. For seizures, the studied doses are higher, around 2.5 to 4.5 mg/kg twice daily. Most veterinary sources recommend starting at the lower end and increasing gradually while monitoring your dog’s response. For a 20 kg (44 lb) dog, a starting arthritis dose would be roughly 20 to 40 mg of CBD twice daily.
Long-term safety data supports daily use for up to 36 weeks at doses up to 10 mg/kg per day, though the practical sweet spot appears to be around 2 to 5 mg/kg daily. Higher doses increase the likelihood of soft stools and more pronounced liver enzyme changes without a clear corresponding increase in benefits for most conditions.
Products vary enormously in concentration. A “dropper full” from one bottle might deliver 5 mg of CBD while another delivers 50 mg. Always calculate the dose based on the milligrams of CBD per milliliter listed on the product (and verified by the COA), not by volume alone.